IASTM Versus PRT in Patients With Chronic PF

NCT ID: NCT05754697

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-15

Study Completion Date

2023-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial\] is to compare between the effect of instrument assisted soft tissue mobilization and positional release technique in patients with chronic plantar fasciitis

The main question\[s\] it aims to answer are:

1. Is there a difference between the effect of instrument assisted soft tissue mobilization and positional release technique on pain pressure threshold in patients with chronic plantar fasciitis?
2. Is there a difference between the effect of instrument assisted soft tissue mobilization and positional release technique on foot function level in patients with chronic plantar fasciitis?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Design of the study:

Pretest - posttest randomized controlled trial.

Subjects selection:

Sixty patients their age range from 30-50 years of both genders with chronic plantar fasciitis will participate in this study according to sample size calculation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Plantar Fasciitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

instrument assisted soft tissue mobilization in addition to traditional treatment

study group

Group Type EXPERIMENTAL

Instrument assisted soft tissue mobilization in addition to traditional treatment

Intervention Type OTHER

The treatment protocol will be two sessions will be given per week for 4 weeks.

positional release technique in addition to traditional treatment

study group

Group Type EXPERIMENTAL

Positional release technique in addition to traditional treatment

Intervention Type OTHER

The treatment protocol will be two sessions will be given per week for 4 weeks.

traditional treatment

control group

Group Type ACTIVE_COMPARATOR

Traditional treatment

Intervention Type OTHER

The treatment protocol will be two sessions will be given per week for 4 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Instrument assisted soft tissue mobilization in addition to traditional treatment

The treatment protocol will be two sessions will be given per week for 4 weeks.

Intervention Type OTHER

Positional release technique in addition to traditional treatment

The treatment protocol will be two sessions will be given per week for 4 weeks.

Intervention Type OTHER

Traditional treatment

The treatment protocol will be two sessions will be given per week for 4 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Clinically diagnosed cases of plantar fasciitis not less than 3 months.
2. Heel pain felt maximally over plantar aspect of heel.
3. Pain in the heel on the first step in the morning.
4. Their age ranging from 30-50 years.
5. Body mass index range from (18.5 to 24.9 kg/m2).

Exclusion Criteria

1. Subjects can't tolerate close physical contact.
2. Athletes.
3. Subjects with skin infections.
4. Subjects with recent fracture with incomplete bony union.
5. Subjects with acute inflammatory or infectious process.
6. Subjects with hematoma.
7. Subjects with osteoporosis.
8. Subjects with foot deformity.
9. Subjects that take medications that may increase blood clotting.
10. Surgery to the ankle or foot.
Minimum Eligible Age

30 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Doaa Said Mohamed Ibrahim

Assistant Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Doaa Ibrahim

Role: PRINCIPAL_INVESTIGATOR

Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Private Clinic

Port Said, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/003841

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.